Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United States.
about
Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United States.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Long-Term Safety and Efficacy ...... nt Study in the United States.
@en
Long-term safety and efficacy ...... United States BLISS-76 trial.
@nl
type
label
Long-Term Safety and Efficacy ...... nt Study in the United States.
@en
Long-term safety and efficacy ...... United States BLISS-76 trial.
@nl
prefLabel
Long-Term Safety and Efficacy ...... nt Study in the United States.
@en
Long-term safety and efficacy ...... United States BLISS-76 trial.
@nl
P2093
P2860
P356
P1476
Long-Term Safety and Efficacy ...... nt Study in the United States.
@en
P2093
Barbara Wilson
Cynthia Aranow
Daniel J Wallace
David A Roth
David Gordon
James Fettiplace
Prafull Mistry
Richard A Furie
P2860
P304
P356
10.1002/ART.40439
P577
2018-04-25T00:00:00Z